BRIDGET STARNER: Open Payments
NPI 1659848794 · DEPEW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 56 payments from 20 companies in 2025. Trend: 2023 $1,605 · 2024 $1,056 · 2025 $1,160
Food & beverage: $1,160
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $237 |
| Novo Nordisk Inc | 6 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $97 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| Amgen Inc. | 4 | $63 |
| GlaxoSmithKline, LLC. | 4 | $59 |
| PFIZER INC. | 3 | $57 |
| Exact Sciences Corporation | 3 | $53 |
| Corcept Therapeutics | 3 | $50 |
| Daiichi Sankyo Inc. | 2 | $43 |
Products named: Ozempic, ENTYVIO, DUPIXENT, JARDIANCE, OTEZLA, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, MOUNJARO.
Industry payments across NY — which companies pay providers there.
